Skip to content
Independent analysis of NHS open data
PharmaInsight

Ofatumumab

Malignant Disease and Immunosuppression Drugs affecting the immune response BNF 0802040BD
Data updated May 2026 Download CSV

Ofatumumab was ranked 1676th of 1,796 medicines by items in May 2026, with 2 items.

2items

Dispensed in May 2026

9items

Rolling 12 months

£2,985

Net ingredient cost · May 2026

Figure 1. Ofatumumab: national items dispensed by month

0 1.5 3 Oct 2025 Dec 2025 Jan 2026 Feb 2026 May 2026 2 Oct 2025: 1 Dec 2025: 3 Jan 2026: 1 Feb 2026: 2 May 2026: 2

Source: NHSBSA Prescription Cost Analysis, to May 2026

Download CSV
Embed this chart

Free to reuse with the credit line above.

At a glance

  • Therapeutic class Drugs affecting the immune response
  • Presentations 1 shown
  • Average cost / item £1,492.50
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, May 2026

The individual products dispensed under Ofatumumab this month.

Presentations of Ofatumumab, May 2026
Presentation BNF code Items Net ingredient cost
Kesimpta Sensoready 20mg/0.4ml inj pre-filled pens 0802040BDBBAAAA 2 £2,985

Source: NHSBSA Prescription Cost Analysis · to May 2026 OGL v3.0

Where Ofatumumab is dispensed

The regions and dispensing practices with the highest Ofatumumab volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

In NHS hospitals

Ofatumumab is also used in NHS secondary care. See the indicative hospital cost, monthly trend and the trusts using it most on the hospital medicines page.

Compare Ofatumumab with

Other medicines in the same BNF section, by prescribing volume.

Download this data

The monthly series for Ofatumumab is in this page's CSV. For the ranked national series across every medicine, with the method and caveats documented, see the most-prescribed medicines dataset in our open data catalogue.